Effects of brain stimulation on loneliness in older adults

Utilizing Transcranial Direct Current Stimulation (tDCS) to Boost Social Pleasure and Participation in Older Lonely Individuals

NA · The University of Hong Kong · NCT05937022

This study is testing whether a type of brain stimulation can help lonely older adults feel more connected and motivated to engage socially.

Quick facts

PhaseNA
Study typeInterventional
Enrollment135 (estimated)
Ages60 Years and up
SexAll
SponsorThe University of Hong Kong (other)
Locations1 site (Hong Kong)
Trial IDNCT05937022 on ClinicalTrials.gov

What this trial studies

This clinical trial investigates the impact of transcranial direct current stimulation (tDCS) on social and emotional functions in lonely older adults aged 60 and above. Participants will undergo 10 sessions of tDCS to assess its effectiveness in enhancing positive social processing and motivation, potentially leading to increased social activity and reduced feelings of loneliness. The study aims to evaluate both the immediate and long-term effects of the intervention on participants' social engagement and emotional well-being. The trial will also explore the safety and efficacy of tDCS as a novel intervention for loneliness in this demographic.

Who should consider this trial

Good fit: Ideal candidates are lonely older adults aged 60 or above who are fluent in Traditional Chinese and meet specific cognitive and educational criteria.

Not a fit: Patients with major physical or neurological illnesses, significant cognitive impairments, or those currently undergoing treatments affecting cognitive function may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce loneliness and improve social engagement among older adults.

How similar studies have performed: While tDCS has shown promise in other contexts, its application specifically for reducing loneliness in older adults is novel and has not been extensively tested.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged ≥ 60 years old;
2. Fluent in reading and speaking Traditional Chinese (Cantonese or Mandarin);
3. Right-handed as assessed with the Edinburgh Handedness Inventory;
4. Normal or corrected-to-normal vision and hearing;
5. Normal general cognitive function as determined by the Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) ≥ 22;
6. ≥ 9 years of formal education as lexical comprehension is required in the Emotion Rating Task.

Exclusion Criteria:

1. Current or past major physical or neurological illness that significantly affects the individual's current cognitive, motor, or brain function;
2. Medication or other treatment received within 2 weeks before the study that may affect the individual's current cognitive, motor, or brain function;
3. Receiving maintained therapy that may affect cognitive, motor, or brain function and cannot be discontinued for the entire course of study;
4. Past or present major psychological conditions, including affective disorders, anxiety disorder, psychotic disorder, addiction, and impulse control disorder;
5. Any contraindication of tDCS, such as a cerebral implant or history (either personal or family) of seizure.
6. Participation in similar brain stimulation studies within the past six months.

Where this trial is running

Hong Kong

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Loneliness, Transcranial Direct Current Stimulation, Emotion Regulation, Lateral Prefrontal Cortex, Aging

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.